CAS: 1181226-02-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 4-((3,5-Dichloro-2-hydroxybenzyl)amino)-2-hydroxybenzoic acid REF: IN-DA008TPQCAS: 1181226-02-7 | 98% | To inquire | Fri 15 Nov 24 |
 | ZL006 REF: TM-T17293CAS: 1181226-02-7 | 98.29% | 38.00 €~1,095.00 € | Fri 22 Nov 24 |
 | ZL006 REF: 3D-GXB22602CAS: 1181226-02-7 | Min. 95% | To inquire | Fri 27 Dec 24 |
4-((3,5-Dichloro-2-hydroxybenzyl)amino)-2-hydroxybenzoic acid
CAS:1181226-02-7
Formula:
C14H11Cl2NO4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
328.1474
Ref: IN-DA008TPQ
| 5mg | 151.00 € | ||
| 10mg | 170.00 € | ||
| 25mg | 337.00 € | ||
| 50mg | 525.00 € | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Friday 15 Nov 2024
ZL006
CAS:1181226-02-7
ZL006 is an effective inhibitor of nNOS/PSD-95 interaction. ZL006 also inhibits NMDA receptor-mediated NO synthesis.
Formula:
C14H11Cl2NO4
Purity:
98.29%
Color and Shape:
Solid
Molecular weight:
328.15
Ref: TM-T17293
| 5mg | 50.00 € | ||
| 10mg | 63.00 € | ||
| 25mg | 113.00 € | ||
| 50mg | 173.00 € | ||
| 100mg | 296.00 € | ||
| 200mg | 428.00 € | ||
| 1mL*10mM (DMSO) | 51.00 € |
Estimated delivery in United States, on Friday 22 Nov 2024
ZL006
CAS:1181226-02-7
ZL006 is a potential drug target that has been shown to inhibit the activity of …
Formula:
C14H11Cl2NO4
Purity:
Min. 95%
Molecular weight:
328.15 g/mol
Ref: 3D-GXB22602
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Friday 27 Dec 2024
